44 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
applicable state and federal data privacy and security laws and regulations, including without limitation HIPAA, and the Company and its subsidiaries … reasonably designed to ensure compliance in all material respects with their policies and procedures relating to data privacy and security
8-K
EX-10.1
yrug6i5auenbh5w
2 May 22
Tempest Announces Private Placement Financing of $15 Million
8:02am
PRE 14A
3o1rt9rcrlj3h
22 Apr 22
Preliminary proxy
4:01pm
8-K
EX-1.1
7f1d9 z6fjwpzd3upre2
23 Jul 21
Other Events
5:20pm
424B3
yqhlkyy fem
11 May 21
Prospectus supplement
5:19pm